astex.png
Third Success from Astex Drug Discovery Pharma Collaboration and Licence Agreements as AstraZeneca Receives US Marketing Approval for Cancer Drug Truqap (capivasertib)
November 20, 2023 04:29 ET | Astex Pharmaceuticals
AstraZeneca’s Truqap™ (capivasertib) in combination with Faslodex® (fulvestrant) receives US FDA marketing approval for the treatment of adult patients with hormone receptor (HR)-positive,...
astex.png
Astex Expands Drug Discovery Collaboration With MSD
August 08, 2023 04:00 ET | Astex Pharmaceuticals
CAMBRIDGE, United Kingdom, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals (UK) (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small molecule...
astex.png
Astex and Cardiff University Medicines Discovery Institute Announce New Drug Discovery Collaboration on Neurodegenerative Diseases
February 13, 2023 04:00 ET | Astex Pharmaceuticals
CAMBRIDGE and CARDIFF, United Kingdom, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals (UK) (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small...
Harren Jhoti CEO Astex Pharmaceuticals (UK) with CryoEM facility used in drug discovery - copyright Astex  Pharmaceuticals (UK) Dec 2022
Astex Co-founder and CEO Harren Jhoti Awarded OBE in the King’s New Year Honours
December 31, 2022 04:58 ET | Astex Pharmaceuticals
CAMBRIDGE, United Kingdom, Dec. 31, 2022 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, UK, congratulates Harren Jhoti, PhD, FRS, FMedSci, its co-founder, President and CEO on being honoured in the 2023...